Cubist Names Dr. Lorianne Masuoka Chief Medical Officer 13 Jun 2013 | 09:00 pm

Lexington, Mass., June 13, 2013 – Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced the appointment of Dr. Lorianne Masuoka to Chief Medical Officer and Senior Vice President, Clinical Devel...

Big Pharma Exit: Who's Fighting the Superbugs? 24 Apr 2013 | 09:00 pm

Cave Explorer Hunts Antibiotics 1,600 Feet Down 27 Feb 2013 | 10:00 pm

In a remote cave 1,600 feet below New Mexico’s Carlsbad Caverns National Park, Hazel Barton, a microbiologist working with Cubist Pharmaceuticals Inc. (CBST), has found a drug-resistant bacteria that ...

Cubist to Appoint Tom DesRosier as Senior Vice President, Chief Legal Officer and Secretary 8 Jan 2013 | 10:00 pm

LEXINGTON, Mass.-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Thomas J. DesRosier will be joining the Company as Senior Vice President, Chief Legal Officer and Secretary. Mr. Des...

Cubist Announces Full-Year 2012 Revenues and Provides Business Update 7 Jan 2013 | 10:00 pm

LEXINGTON, Mass.--(BUSINESS WIRE)-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced unaudited fourth quarter and full-year 2012 revenues and provided business updates, including the expect...

Cubist Submits ENTEREG Supplemental NDA 21 Dec 2012 | 10:00 pm

LEXINGTON, Mass.-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that it has submitted a supplemental new drug application (sNDA) to the U.S. Food and Drug Administration (FDA) requestin...

FDA Grants QIDP Designation to Two Cubist Phase 3 Antibiotic Candidates 6 Dec 2012 | 10:00 pm

LEXINGTON, Mass.-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that the U.S. Food and Drug Administration (FDA) has designated two of the company’s Phase 3 antibiotic candidates, CXA-2...

BioCentury TV "Antibiotic Wars" featuring Cubist's Dr. Barry Eisenstein 27 Nov 2012 | 10:00 pm

Join Washington Editor Steve Usdin's conversation with six key players in the effort to reverse the collapse of antibiotic drug development.

BioCentury TV "Antibiotic Wars" featuring Cubist's Dr. Barry Eisenstein 27 Nov 2012 | 10:00 pm

Join Washington Editor Steve Usdin's conversation with six key players in the effort to reverse the collapse of antibiotic drug development.

Cubist Appoints Patrick Vink as Senior Vice President and General Manager of International Business 4 Sep 2012 | 09:00 pm

LEXINGTON, Mass.-- Cubist Pharmaceuticals, Inc. (NASDAQ: CBST) today announced that Patrick Vink, M.D., has joined the Company as Senior Vice President and General Manager of its International Busines...